MET INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving MetLife, Inc. and a Lead Plaintiff Deadline of April 6, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of investors who purchased MetLife, Inc. ("MetLife") (NYSE: MET) securities between February 27, 2013 and January 29, 2018.

Click here to learn about the case: http://www.wongesq.com/pslra-sbm/metlife-inc?wire=2. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) MetLife’s practices and procedures used to estimate its reserves set aside for annuity and pension payments were inadequate; (2) MetLife had inadequate internal controls over financial reporting; and (3) as a result, defendants’ statements about MetLife’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you suffered a loss in MetLife you have until April 6, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sbm/metlife-inc?wire=2.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

The Law Offices of Vincent Wong
Vincent Wong, Esq., 212.425.1140
39 East Broadway
Suite 304
New York, NY 10002
Fax. 866.699.3880
vw@wongesq.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.